Bragar Eagel & Squire, P.C. is Investigating Ligand Pharmaceuticals Incorporated (LGND) on Behalf of Stockholders and Encourages LGND Investors to Contact the Firm
29. Januar 2019 12:34 ET
|
Bragar Eagel & Squire
NEW YORK, Jan. 29, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against Ligand Pharmaceuticals Incorporated (NASDAQ: LGND). Our investigation concerns...
Bragar Eagel & Squire, P.C. is Investigating Ligand Pharmaceuticals Incorporated (LGND) on Behalf of Stockholders and Encourages LGND Investors to Contact the Firm
17. Januar 2019 12:45 ET
|
Bragar Eagel & Squire
NEW YORK, Jan. 17, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against Ligand Pharmaceuticals Incorporated (NASDAQ: LGND). Our investigation concerns...
Lawsuit for Investors in Ligand Pharmaceuticals Inc. (NASDAQ:LGND) over alleged Violations of Securities Laws announced by Shareholders Foundation
29. November 2016 13:35 ET
|
Shareholders Foundation, Inc.
SAN DIEGO, Nov. 29, 2016 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit was filed in California on behalf of certain purchasers of shares of Ligand Pharmaceuticals...